BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36446307)

  • 21. Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma.
    Benedix F; Meyer F; Kube R; Kropf S; Kuester D; Lippert H; Roessner A; Krüger S
    Pathol Res Pract; 2012 Oct; 208(10):592-7. PubMed ID: 22898351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers.
    Sinicrope FA; Rego RL; Foster N; Sargent DJ; Windschitl HE; Burgart LJ; Witzig TE; Thibodeau SN
    Am J Gastroenterol; 2006 Dec; 101(12):2818-25. PubMed ID: 17026563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features.
    Kazama Y; Watanabe T; Kanazawa T; Tanaka J; Tanaka T; Nagawa H
    J Clin Pathol; 2007 Jun; 60(6):701-4. PubMed ID: 17557871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medullary carcinoma of the colon: a case series and review of the literature.
    Cunningham J; Kantekure K; Saif MW
    In Vivo; 2014; 28(3):311-4. PubMed ID: 24815832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
    Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic features and prognostic analysis of MSI-high colon cancer.
    Lin CC; Lai YL; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Lan YT; Liang WY; Hsu HM; Lin JK; Chang SC
    Int J Colorectal Dis; 2012 Mar; 27(3):277-86. PubMed ID: 22076610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in sporadic colon cancer with high-level microsatellite instability.
    Oh BY; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Surgery; 2016 May; 159(5):1372-81. PubMed ID: 26775578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report.
    El Agy F; El Bardai S; El Otmani I; Benbrahim Z; Karim MH; Mazaz K; Benjelloun EB; Ousadden A; El Abkari M; Ibrahimi SA; Chbani L
    PLoS One; 2021; 16(3):e0248522. PubMed ID: 33784337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
    Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
    World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid-type poorly differentiated adenocarcinoma of the stomach: clinicopathological and molecular characteristics and histogenesis.
    Arai T; Matsuda Y; Aida J; Takubo K; Ishiwata T
    Gastric Cancer; 2019 Mar; 22(2):314-322. PubMed ID: 30088163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
    Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database.
    Uhlig J; Cecchini M; Sheth A; Stein S; Lacy J; Kim HS
    J Natl Compr Canc Netw; 2021 Feb; 19(3):307-318. PubMed ID: 33530058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric medullary carcinoma: clinicopathological features and prognosis-a single-center study.
    Uprak TK; Akmercan A; Coşkun M; Attaallah W
    ANZ J Surg; 2021 Nov; 91(11):2425-2429. PubMed ID: 34405504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer.
    Chouhan H; Sammour T; L Thomas M; W Moore J
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):69-74. PubMed ID: 30421554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
    Shaib WL; Zakka KM; Jiang R; Yan M; Alese OB; Akce M; Wu C; Behera M; El-Rayes BF
    Cancer; 2020 Sep; 126(18):4136-4147. PubMed ID: 32697360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.
    Ruemmele P; Dietmaier W; Terracciano L; Tornillo L; Bataille F; Kaiser A; Wuensch PH; Heinmoeller E; Homayounfar K; Luettges J; Kloeppel G; Sessa F; Edmonston TB; Schneider-Stock R; Klinkhammer-Schalke M; Pauer A; Schick S; Hofstaedter F; Baumhoer D; Hartmann A
    Am J Surg Pathol; 2009 May; 33(5):691-704. PubMed ID: 19252434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal instability in microsatellite-unstable and stable colon cancer.
    Trautmann K; Terdiman JP; French AJ; Roydasgupta R; Sein N; Kakar S; Fridlyand J; Snijders AM; Albertson DG; Thibodeau SN; Waldman FM
    Clin Cancer Res; 2006 Nov; 12(21):6379-85. PubMed ID: 17085649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas.
    Kalady MF; Sanchez JA; Manilich E; Hammel J; Casey G; Church JM
    Dis Colon Rectum; 2009 Jun; 52(6):1039-45. PubMed ID: 19581844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.